Dietmar R. Lohmann
Essen, NW, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 61 publications
MYCN Amplification in RB1-Inactivated Retinoblastoma: Association With High-Risk Features.
Journal: Pediatric blood & cancer
Published: October 14, 2025
Presence of tumor DNA in aqueous humor is correlated with high risk uveal melanoma.
Journal: Scientific reports
Published: December 21, 2024
Author Correction: A MYCN-driven de-differentiation profile identifies a subgroup of aggressive retinoblastoma.
Journal: Communications biology
Published: September 11, 2024
Retinoblastoma caused by an RB1 variant with unusually low penetrance in a Danish family.
Journal: European journal of medical genetics
Published: February 12, 2024
A MYCN-driven de-differentiation profile identifies a subgroup of aggressive retinoblastoma.
Journal: Communications biology
Published: December 13, 2023
Release of Cell-Free Tumor DNA in the Plasma of Uveal Melanoma Patients Under Radiotherapy.
Journal: Investigative ophthalmology & visual science
Published: October 20, 2023
Adjuvant therapy for children treated by enucleation at diagnosis of retinoblastoma.
Journal: EJC paediatric oncology
Published: November 10, 2022
Monoallelic and biallelic mutations in RELN underlie a graded series of neurodevelopmental disorders.
Journal: Brain : a journal of neurology
Published: February 03, 2022
TFF1 in Aqueous Humor-A Potential New Biomarker for Retinoblastoma.
Journal: Cancers
Published: January 04, 2022
Comparing efficacy and side effects of two systemic chemotherapy regimens for eye-preserving therapy in children with retinoblastoma.
Journal: Pediatric blood & cancer
Published: June 01, 2021
Last Updated: 09/26/2026